DIA Data Science Conference

Overview

Conference: November 14-15

The aim of this forum is to bring together data-minded professionals from regulatory agencies, pharmaceutical, device and biotechnology industries, and data organizations to discuss the growing role and applicability of data science in drug development as well as the integration and regulatory challenges and considerations of data science. This forum offers a platform for experts in regulatory science, clinical development, and data science to deliver deep-dive relevant perspectives and to share pertinent case examples of data science application. It will provide the opportunity to collaborate in breakout rooms with cross industry and regulatory colleagues and explore new ideas and applications, common research questions, and topics relevant to the development process and business needs.

Program Committee

Joan Buenconsejo, PhD, MPH • Head of Cardiovascular and Early Development Biostatistics
Bristol Myers Squibb, United States
Pritibha Singh, MBA, MSc • Global Program Associate Director, Oncology Hematology Development
Novartis AG, Switzerland
Ruthie Davi, PhD, MS • Vice President, Data Science and Statistician
Medidata, a Dassault Systèmes company, United States
Nan Shao, PhD • CVP, Global Head of Analytics Strategy
Parexel International, United States
Steve Wilson, PhD • Senior Staff Fellow, OB, OTS, CDER
FDA, United States
Jingjing Ye, PhD • Executive Director, Global Head of Data Science & Operational Excellence (DSOE)
Global Statistics and Data Science (GSDS), BeiGene USA, United States
Jessica Federer, MPH • Partner
Boston Millennia Partners, United States
Jerald Schindler, DrPH • Vice President, Biostatistics
Alkermes Pharmaceticals, United States
Rebecca Taha, PhD, MBA • Statistical Consulting Director
ICON Biotech Solutions, United States
Chava Zibman, PhD • Mathematical Statistician, CDRH
FDA, United States
Representative Invited • DIA, United States